The page opens with a plain-language overview of what this body of research does and does not show, followed by every study cited across the site, listed alphabetically by first author. Tags indicate which section or practice each reference supports.
In Parkinson's, the cells that produce dopamine in a small region deep in the brain gradually die. Dopamine is what the brain's movement circuitry uses to start a movement and set its size. Without enough of it, movements become slow, small and effortful, tremor can appear, and walking can suddenly stop altogether — the experience known as freezing.
The part people notice first is often the strangest. Movements that used to happen by themselves — swinging an arm, taking a step, writing your signature — stop being automatic. They still work, but only if you consciously attend to them. This is why so much of what helps in Parkinson's is essentially an attention trick: counting steps, marching to a beat, stepping over a line on the floor.
The research on this page asks whether attention itself can be trained. If watching a movement, imagining one, or deliberately calming the body can reach the motor system by a route not dependent on the damaged dopamine circuit, these might be useful additions to conventional treatment.
Watching someone perform an action, and imagining performing it yourself, both activate motor areas of the brain without any movement occurring. The proposal in Parkinson's is specific: these routes run mainly through the outer layers of the brain — premotor and parietal cortex — which are relatively spared, and so may partly bypass the damaged circuitry deeper down (Caligiore et al., 2017; Abbruzzese et al., 2015).
That is a hypothesis about mechanism, and worth saying so plainly. It explains why the idea is attractive; it does not demonstrate that it works.
There is a wrinkle here that does not arise in other conditions. Parkinson's slows imagined movement as well as real movement: when people are asked to imagine a task and the time is measured, the imagined movement is slowed much as the physical one is (Heremans et al., 2012). The imagination is affected by the very thing it is being asked to treat.
The same study found something useful, though. When visual cues were provided during the imagery, the slowing reduced and the images became more vivid. Imagery ability also varies between individuals, appears to relate to symptom severity (Readman et al., 2023), and can be measured formally (Malouin et al., 2007). This suggests guided imagery for Parkinson's should be cued and structured rather than left to the person's own imagination.
Timing may matter too, though here the evidence is theory, not proof. The body cycles between alertness and rest roughly every ninety minutes (Kleitman, 1963; Rossi & Nimmons, 1991), the drowsy state before sleep is linked to unusually vivid, spontaneous imagery (Mavromatis, 1987; Schacter, 1976; Ghibellini & Meier, 2023), and sleep helps consolidate a skill practised earlier in the day (Walker et al., 2002; Stickgold & Walker, 2007). None of this has been tested with imagery in Parkinson's — it is a reason to place a session at a particular time of day, not evidence that doing so helps.
The first trial combined motor imagery with physical practice in a group setting: twelve people received both, eleven physical practice alone, twice a week for twelve weeks. The combined group ended up faster at movement sequences and scored better on the standard Parkinson's rating scale, and the authors noted it extends practice time at low cost and negligible risk (Tamir et al., 2007). It was a small study.
Watching movement has shown short-term effects. A single session of watching video of repetitive finger movements increased spontaneous movement speed, still measurable two days later, while video of a static hand did nothing (Pelosin et al., 2013). Combining observation with imagery influences the size of hand movements (Bek et al., 2019), and a home training programme built around this has been developed with patients themselves (Bek et al., 2021). Trials pairing imagery with virtual reality report gains in balance, motor function and daily activities (Kashif et al., 2022a, 2022b).
Against this sit two results that must be given equal weight. A randomised trial found action observation and motor imagery had no effect on balance or freezing of gait (Bezerra et al., 2022). And the most recent meta-analysis pooled the trials using the standard motor rating scale as their main outcome — six studies, 152 people — and found no difference between treatment and comparison groups, whether tested on or off medication (Pettenuzzo et al., 2025).
The picture is different, and in some ways stronger, for the calming side of this work. In twenty people with moderate to severe tremor, relaxation guided imagery reduced tremor dramatically on accelerometer measurement, and abolished it entirely for between one and thirteen minutes in fifteen of them. Tremor remained below baseline half an hour later, and participants reported benefit lasting several hours. Relaxing music helped less; relaxing without guidance did not help at all (Schlesinger et al., 2009). A later study from the same group reported reduced motor fluctuations (Schlesinger et al., 2014).
For mood, a randomised trial in JAMA Neurology found mindfulness yoga improved anxiety and depression more than stretching and resistance training (Kwok et al., 2019). A mindfulness programme has been associated with structural changes on brain scans (Pickut et al., 2013), and a small uncontrolled study reported improvements in anxiety, depression, cognition and some motor measures (Dissanayaka et al., 2016).
Voice work sits alongside this as an established, separately evidenced treatment, with benefits demonstrated at two years and measurable changes in brain activity (Ramig et al., 2001; Narayana et al., 2010; Fox et al., 2012).
The honest position has four parts.
First, on the standard measure of Parkinson's motor symptoms, the pooled evidence for imagery and observation is null (Pettenuzzo et al., 2025). Six trials and 152 people is a very small body of evidence, and the encouraging studies are mostly small and short.
Second, the freezing and balance results are actively negative, not merely uncertain (Bezerra et al., 2022). Freezing is among the most distressing symptoms, and it would be wrong to imply this approach addresses it.
Third, the relaxation findings, striking as they are, come from small unblinded studies of an outcome — tremor — known to respond to attention and stress. That does not make the effect unreal; anyone with Parkinson's knows what stress does to their tremor. But its size should be treated cautiously.
Fourth, and most importantly, none of this substitutes for exercise or medication. The largest evidence base in Parkinson's rehabilitation covers physical exercise: 154 trials and nearly 7,800 people, showing benefit for motor symptoms and quality of life across almost every type studied (Ernst et al., 2024). The intervention with the strongest evidence here is moving, not imagining.
Two rather different claims are gathered on this site, and they deserve to be held to different standards.
Imagery and observation for movement are mechanistically plausible and supported by some encouraging small trials, but the pooled evidence on the standard motor scale shows no benefit yet. It is reasonable to try; it would not be reasonable to promise.
Imagery and mindfulness for tremor, fluctuations, anxiety and mood rest on firmer ground, including a randomised trial in a major neurology journal. Stress makes Parkinson's symptoms worse in a way people recognise immediately in their own bodies, and practices that reduce it address something real.
What both share is a favourable balance of risk. No harm has been reported in any of these studies. They cost nothing, need no equipment, and can be practised on days when a walk is not possible. Used alongside exercise, medication and your clinical team — not in place of them — they are reasonable to add.
This overview summarises published research and is not medical advice. Never change medication or treatment without speaking to your neurologist or Parkinson's nurse.